Since early in our company’s history, we’ve been deeply committed to advancing care for systemic mastocytosis as we aim to address unmet patient needs. This month, members of our Blue Crew joined us to talk about their efforts to support this goal, the need to improve SM diagnostic rates and how the SM patient community inspires them.
Hear more about International Mastocytosis and Mast Cell Diseases Awareness Day from our Blue Crew:
VP, Health Economics & Outcomes Research
Associate Director, Patient Advocacy
Director, HCP Marketing
VP of Europe North and Director of Operations
Regional VP and General Manager, EU South